Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

t(1;14)(q21;q32) FCRL4/IGH

Written2004-12Mary Callanan, Dominique Leroux
Lymphoma Research Group - Groupe de Recherche sur les Lymphomes - EMI0353, Institut Albert Bonniot, Université Joseph Fourier Grenoble 1, La Tronche 38706, France

(Note : for Links provided by Atlas : click)

Identity

ICD-Topo C420,C421,C424 BLOOD, BONE MARROW, & HEMATOPOIETIC SYS
Atlas_Id 1375
Note This translocation with IRTA1 involvement is different from t(1;14)(q21;q32) with BCL9 involvement, from the t(1;14)(q21;q32) with FCGR2B involvement, and from the t(1;14)(q21;q32) with MUC1 involvement.

Clinics and Pathology

Disease Multiple Myeloma and B-cell non-Hodgkins lymphoma
Epidemiology Rare. 2 published cases : 1 in a multiple myeloma cell line. The second in a case of gastric diffuse large B-cell lymphoma (DLBCL).
Prognosis Unknown

Genetics

The t(1;14) interrupts the IRTA gene locus (Immunoglobulin superfamily Receptor Translocation Associated gene locus) which spans approximately 250kb, between the IRTA1 and IRTA2 genes.

Genes involved and Proteins

Gene Name FCRL4
Location 1q21
Dna / Rna IRTA1 localises to the IRTA gene locus. Three IRTA1 transcripts of 2.5kb, 2.7kb and 3.5kb are possible due to alternate usage of 3 polyadenylation sites.
Protein The three alternate IRTA1 transcripts give rise to the same putative 515 amino acid protein. The protein shows a signal peptide, four extracellular Ig-type domains carrying three potential asparagaine (N)-linked glycosylation sites, a 16 amino acid transmmbrane and a 106 amino acid cytoplasmic domain with three putative consensus Src-homology 2 SH2 binding domains. These domains show similarity to both ITAM (Immunoreceptor Tyrosine-based Activation Motifs) and ITIM (Immunoreceptor Tyrosine-based Inhibition Motifs). The function of the protein is unknown. It is expressed in marginal zone B cells. In the extracellular domain IRTA1 protein shows homology to Ig superfamily receptors (47% identity and 51% similarity) and Fc receptor family (37% identity and 50% similarity). In the intracellular domain, IRTA1 shows striking homology to PECAM1 (31% identity and 45% homology).
Gene Name IGH
Location 14q32

Result of the chromosomal anomaly

Fusion Protein
Description Expression of IRTA1 fusion proteins. In the first case described the t(1;14) juxtaposes the IRTA1 gene to the C alpha constant gene in the same transcriptional orientation on the der(14) chromosome. An IRTA1/C alpha fusion protein results from this. The predicted fusion protein fuses the signal peptide and first two extracellular residues of IRTA1 to the C alpha encoded transmembrane and cytoplasmic domains.
Overexpression of IRTA1 was not observed in other myeloma or lymphoma cell lines, regardless of the status of its chromosomal band 1q21.
More recently long distance inverse PCR cloning identified a second case of IRTA1 translocation to IGH switch sequence (Switch gamma 3) in a case of gastric DLBCL.
In contrast, IRTA2 gene (located telomeric of IRTA1 in the IRTA gene locus) shows frequent deregulation in Burkitt lymphoma and Multiple Myeloma cell lines with 1q21 abnormalities (mostly duplications or unbalanced translocations that lead to trisomy or tetrasomy 1q).
IRTA1 is normally expressed in marginal zone B cells while IRTA2 is selectively expressed in centrocytes, marginal zone B cells and immunoblasts.
IRTA1 and 2 have been independently cloned as FcRH4 and FcRH5 (Fc Receptor Homologues) from a human lymph node cDNA library.
  

Bibliography

Identification of a family of Fc receptor homologs with preferential B cell expression.
Davis RS, Wang YH, Kubagawa H, Cooper MD.
Proc Natl Acad Sci U S A. 2001; 98: 9772-9777.
PMID 11493702
 
Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT).
Falini B, Tiacci E, Pucciarini A, Bigerna B, Kurth J, Hatzivassiliou G, Droetto S, Galletti BV, Gambacorta M, Orazi A, Pasqualucci L, Miller I, Kuppers R, Dalla-Favera R, Cattoretti G.
Blood. 2003; 102: 3684-3692.
PMID 12881317
 
IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy.
Hatzivassiliou G, Miller I, Takizawa J, Palanisamy N, Rao PH, Iida S, Tagawa S, Taniwaki M, Russo J, Neri A, Cattoretti G, Clynes R, Mendelsohn C, Chaganti RS, Dalla-Favera R.
Immunity. 2001; 14: 277-89.
PMID 11290337
 
Rapid amplification of immunoglobulin heavy chain switch (IGHS) translocation breakpoints using long-distance inverse PCR.
Sonoki T, Willis TG, Oscier DG, Karran EL, Siebert R, Dyer MJ.
Leukemia. 2004; 18: 2026-2031.
PMID 15496980
 

Citation

This paper should be referenced as such :
Callanan, M ; Leroux, D
t(1;14)(q21;q32) IRTA1/IGH
Atlas Genet Cytogenet Oncol Haematol. 2005;9(1):26-27.
Free journal version : [ pdf ]   [ DOI ]
On line version : http://AtlasGeneticsOncology.org/Anomalies/t0114q21q32ID1375.html


Translocations implicated (Data extracted from papers in the Atlas)

 t(1;14)(q21;q32) FCRL4/IGH

External links

arrayMap (UZH-SIB Zurich)
Mitelman databaset(1;14)(q21;q32) [Case List]    t(1;14)(q21;q32) [Association List] Mitelman database (CGAP - NCBI)
arrayMap[select an item]
 
 
Disease databaset(1;14)(q21;q32) FCRL4/IGH
REVIEW articlesautomatic search in PubMed
Last year articlesautomatic search in PubMed
All articlesautomatic search in PubMed


© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Tue Mar 14 13:54:20 CET 2017


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.